Monica Simeoni
Brentford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 09, 2026
Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumab.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: July 21, 2023
Longitudinal Model-Based Meta-Analysis of Lung Function Response to Support Phase III Study Design in Chinese Patients With Asthma.
Journal: Clinical pharmacology and therapeutics
Published: October 22, 2021
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Journal: British journal of clinical pharmacology
Published: April 30, 2021
Response to Inhibition of Receptor-Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo-Controlled Study.
Journal: Clinical pharmacology and therapeutics
Published: October 28, 2019
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: May 23, 2018
Population Pharmacokinetic Modelling for Estimation of Remifentanil Metabolic-Ratio Using Non-steady-State Concentrations under Rapidly Adaptive Dosing.
Journal: Pharmaceutical research
Published: March 29, 2018
Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers.
Journal: Pharmacology research & perspectives
Published: September 18, 2017
Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study.
Journal: The British journal of dermatology
Published: January 06, 2016
First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study.
Journal: PloS one
Published: December 20, 2013
Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer's disease: a phase I study.
Journal: Alzheimer's research & therapy
Published: December 13, 2013
Modeling of human tumor xenografts and dose rationale in oncology.
Journal: Drug discovery today. Technologies
Published: September 21, 2013
Last Updated: 09/26/2026